@article{7b7a50c2425947a9939021006c33f13f,
title = "Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.",
keywords = "PLUS ZOLEDRONIC ACID, CLINICAL-PRACTICE, BONE LOSS, THERAPY, WOMEN, BISPHOSPHONATES, INHIBITOR, RANKL, METAANALYSIS, PREVENTION",
author = "Michael Gnant and Georg Pfeiler and Steger, \{G{\"u}nther G\} and Daniel Egle and Richard Greil and Florian Fitzal and Viktor Wette and Marija Balic and Ferdinand Haslbauer and Elisabeth Melbinger-Zeinitzer and Vesna Bjelic-Radisic and Raimund Jakesz and Christian Marth and Paul Sevelda and Brigitte Mlineritsch and Ruth Exner and Christian Fesl and Sophie Frantal and Singer, \{Christian F\}",
note = "Greil: Department of Internal Medicine III, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute–Centre for Clinical Cancer and Immunology Trials, Cancer Cluster Salzburg, Salzburg, Austria; Salzburg Cancer Research Institute, Salzburg, Austria; Mlineritsch: Department of Internal Medicine III, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute–Centre for Clinical Cancer and Immunology Trials, Cancer Cluster Salzburg, Salzburg, Austria ",
year = "2019",
doi = "10.1016/S1470-2045(18)30862-3",
language = "English",
volume = "20",
pages = "339--351",
journal = "LANCET ONCOL",
issn = "1470-2045",
publisher = "Elsevier ",
number = "3",
}